Effectiveness of a standard secondary coronary prevention program: not obligate

Kaynakça (14)

1. Gong Y, Yang F, Hong T, Huo Y. Using a standardized follow-up program to improve coronary heart disease secondary prevention. Anatol J Cardiol 2016; 16: 00-00
2. Onat A, Can G, Örnek E, Çiçek G, Murat SN, Yüksel H. Increased apolipoprotein A-I levels mediate the development of prehypertension. Anatol J Cardiol 2013; 13: 306-14
3. Onat A, Can G. Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharma Design 2014; 20: 575-84
4. Onat A, Dönmez I, Karadeniz Y, Çakır H, Kaya A. Type-2 diabetes and coronary heart disease: common physiopathology, viewed from autoimmunity. Expert Rev Cardiovasc Ther 2014; 12: 667-79
5. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE. Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 2010; 69: 310-4
6. Onat A, Çoban N, Can G, Yüksel M, Karagöz A, Yüksel H, et al. Low "quotient" Lp(a) concentration mediates autoimmune activation and independently predicts cardiometabolic risk. Exp Clin Endocrinol Diabetes 2015; 123: 11-8
7. Mora S, Kamstrup PR, Rifai N, Nordestgaard BG, Buring JE, Ridker PM, et al. Lipoprotein(a) and risk of type-2 diabetes. Clin Chem 2010; 56: 1252-60
8. Ye Z, Haycock PC, Gurdasani D, Pomilla C, Boekholdt SM, Tsimikas S, et al. The association between circulating lipoprotein (a) and type 2 diabetes: is it causal? Diabetes 2014; 63: 332-42
9. Mora S, Akinkuolie AO, Sandhu RK, Conen D, Albert CM. Paradoxical association of lipoprotein measures with incident atrial fibrillation. Circ Arrhythm Electrophysiol 2014; 7: 612-9
10. Onat A, Can G, Ademoğlu E, Çelik E, Karagöz A, Örnek E. Coronary disease risk curve of serum creatinine is linear in Turkish men, Ushaped in women. J Investig Med 2013; 61: 27-33
11. Altay S, Onat A, Özpamuk-Karadeniz F, Karadeniz Y, Kemaloğlu-Öz T, Can G. Renal "hyperfiltrators" are at elevated risk of death and chronic diseases. BMC Nephrol 2014; 15: 160
12. Onat A, Aydın M, Can G, Çelik E, Altay S, Karagöz A, et al. Normal thyroid- stimulating hormone levels, autoimmune activation, and coronary heart disease risk. Endocrine 2015; 48: 218-26
13. Onat A, Köroğlu B, Can G, Karagöz A, Yüksel M, Aydın M. Apparently “low” serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes. Anatol J Cardiol 2014; 14: 26-33
14. Altay S, Onat A, Karadeniz Y, Özpamuk Karadeniz F, Can G. Prediction by low plasma